These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 14752931)

  • 1. [Lymphoproliferative disorders caused by hereditary genetic defects].
    Kanegane H; Miyawaki T
    Nihon Rinsho Meneki Gakkai Kaishi; 2003 Dec; 26(6):311-22. PubMed ID: 14752931
    [No Abstract]   [Full Text] [Related]  

  • 2. The abnormal gene in X-linked lymphoproliferative syndrome.
    Sullivan JL
    Curr Opin Immunol; 1999 Aug; 11(4):431-4. PubMed ID: 10448142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunology. Sinking surveillance's flagship.
    Klein G; Klein E
    Nature; 1998 Oct; 395(6701):441, 443-4. PubMed ID: 9774094
    [No Abstract]   [Full Text] [Related]  

  • 4. XLP: one gene, many players.
    Czar MJ; Schwartzberg PL
    Clin Immunol; 2001 Jul; 100(1):2-3. PubMed ID: 11414739
    [No Abstract]   [Full Text] [Related]  

  • 5. Expression in transgenic mice of dominant interfering Fas mutations: a model for human autoimmune lymphoproliferative syndrome.
    Choi Y; Ramnath VR; Eaton AS; Chen A; Simon-Stoos KL; Kleiner DE; Erikson J; Puck JM
    Clin Immunol; 1999 Oct; 93(1):34-45. PubMed ID: 10497009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular and molecular pathogenesis of X-linked lymphoproliferative disease.
    Moretta A; Bottino C; Parolini S; Moretta L; Biassoni R; Notarangelo LD
    Curr Opin Allergy Clin Immunol; 2001 Dec; 1(6):513-7. PubMed ID: 11964734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [X-linked lymphoproliferative syndrome].
    Kanegane H
    Nihon Rinsho Meneki Gakkai Kaishi; 2002 Feb; 25(1):129-34. PubMed ID: 11963172
    [No Abstract]   [Full Text] [Related]  

  • 8. [X-linked lymphoproliferative syndrome, EBV virus infection and defects in cytotoxicity lymphocyte regulation].
    Malbrán A; Belmonte L; Ruibal-Ares B; Baré P; Bracco MM
    Medicina (B Aires); 2003; 63(1):70-6. PubMed ID: 12673966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why commonplace encounters turn to fatal attraction.
    Sadelain M; Kieff E
    Nat Genet; 1998 Oct; 20(2):103-4. PubMed ID: 9771693
    [No Abstract]   [Full Text] [Related]  

  • 10. Human autoimmune lymphoproliferative syndrome, a defect in the apoptosis-inducing Fas receptor: a lesson from the mouse model.
    Nagata S
    J Hum Genet; 1998; 43(1):2-8. PubMed ID: 9609991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune lymphoproliferative syndrome: types I, II and beyond.
    Chun HJ; Lenardo MJ
    Adv Exp Med Biol; 2001; 490():49-57. PubMed ID: 11505974
    [No Abstract]   [Full Text] [Related]  

  • 12. X-linked lymphoproliferative disease: clinical, diagnostic and molecular perspective.
    Gaspar HB; Sharifi R; Gilmour KC; Thrasher AJ
    Br J Haematol; 2002 Dec; 119(3):585-95. PubMed ID: 12437631
    [No Abstract]   [Full Text] [Related]  

  • 13. Disease-causing SAP mutants are defective in ligand binding and protein folding.
    Li C; Iosef C; Jia CY; Gkourasas T; Han VK; Shun-Cheng Li S
    Biochemistry; 2003 Dec; 42(50):14885-92. PubMed ID: 14674764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [X-linked lymphoproliferative syndrome (XLP)].
    Kawa K
    Ryoikibetsu Shokogun Shirizu; 2000; (32):528-30. PubMed ID: 11212794
    [No Abstract]   [Full Text] [Related]  

  • 15. Autoimmune lymphoproliferative syndromes: genetic defects of apoptosis pathways.
    Rieux-Laucat F; Le Deist F; Fischer A
    Cell Death Differ; 2003 Jan; 10(1):124-33. PubMed ID: 12655301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations of the X-linked lymphoproliferative disease gene SH2D1A mimicking common variable immunodeficiency.
    Soresina A; Lougaris V; Giliani S; Cardinale F; Armenio L; Cattalini M; Notarangelo LD; Plebani A
    Eur J Pediatr; 2002 Dec; 161(12):656-9. PubMed ID: 12447665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct interactions of the X-linked lymphoproliferative syndrome gene product SAP with cytoplasmic domains of members of the CD2 receptor family.
    Lewis J; Eiben LJ; Nelson DL; Cohen JI; Nichols KE; Ochs HD; Notarangelo LD; Duckett CS
    Clin Immunol; 2001 Jul; 100(1):15-23. PubMed ID: 11414741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The SAP and SLAM families in immune responses and X-linked lymphoproliferative disease.
    Engel P; Eck MJ; Terhorst C
    Nat Rev Immunol; 2003 Oct; 3(10):813-21. PubMed ID: 14523387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. X-linked lymphoproliferative syndrome.
    Nelson DL; Terhorst C
    Clin Exp Immunol; 2000 Dec; 122(3):291-5. PubMed ID: 11122230
    [No Abstract]   [Full Text] [Related]  

  • 20. SAP: natural inhibitor or grand SLAM of T cell activation?
    Nichols KE; Koretzky GA; June CH
    Nat Immunol; 2001 Aug; 2(8):665-6. PubMed ID: 11477397
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.